###begin article-title 0
###xml 141 144 <span type="species:ncbi:9606">men</span>
The C677 Mutation in Methylene Tetrahydrofolate Reductase Gene: Correlation with Uric Acid and Cardiovascular Risk Factors in Elderly Korean men
###end article-title 0
###begin p 1
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 283 288 283 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 480 485 480 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 631 632 631 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 730 731 730 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 767 772 767 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 908 913 908 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 1044 1049 1044 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 403 406 <span type="species:ncbi:9606">men</span>
###xml 865 868 <span type="species:ncbi:9606">men</span>
The C677T mutation in the methylene tetrahydrofolate reductase (MTHFR) gene results in elevated homocysteine levels and, presumably, in increased cardiovascular risk. Moreover, elevated homocysteine levels are reportedly associated with high serum uric acid levels. We evaluated the MTHFR genotype and a panel of biochemical, hematological variables, and lifestyle characteristics in 327 elderly Korean men (age range 40-81 yr; mean, 51.87). This study shows that mutation of the MTHFR gene may be a risk for hyperuricemia. The mean uric acid levels for the C/C, C/T and T/T genotypes were 5.54, 5.91 and 6.33 mg/dL, respectively (p=0.000). The T/T genotype was significantly more frequent in subjects with high uric acid levels (p=0.003). Thus, this mutation of the MTHFR gene is implied by the study results to be a risk factor of hyperuricemia in elderly Korean men. However, the relationship between the MTHFR mutation and uric acid metabolism remains unclear. Therefore, further studies are necessary to explain the associated between the MTHFR mutation and elevated uric acid levels, and to examine potential relationships between it and conventional cardiovascular risk factors.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 457 458 457 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 459 460 459 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 473 478 473 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 804 805 804 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 829 834 829 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 115 118 <span type="species:ncbi:9606">man</span>
Methylene tetrahydrofolate reductase (MTHFR) is a cytoplasmic enzyme of which gene located on chromosome 1p36.3 in man. MTHFR catalyze the reduction of 5, 10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, the primary methyl donor for the methylation of homocysteine to methionine. Severe deficiency of MTHFR causes an increase in homocysteine levels and is associated with developmental delay, neurological abnormalities and vascular complications (1-4). The C677T MTHFR mutation involves the substitution of an alanine residue for a valine, which results in a substantial reduction in its thermolabile enzymatic activity. With two copies of the TT variant, serum MTHFR activity is reduced to 30% of that of wild-type (CC), whereas the serum activity of CT heterozygotes is 65% of the wild-type (5). Therefore, the C677T MTHFR mutation is being viewed as a possible genetic contributor to hyper-homocysteinemia.
###end p 3
###begin p 4
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
A direct relation between plasma homocysteine levels and serum uric acid was observed in patients with atherosclerosis and in control subjects (6-10). These findings indicate that the association between the two biochemical variables is indeed strong in the presence of homozygosity for thermolabile MTHFR. This could imply a greater availability of 5, 10-methylenetetrahydrofolate, substrate of the MTHFR reaction, for other metabolic uses, such as the de novo synthesis of purines via 10-formyltetrahydrofolate, with consequent overproduction of uric acid.
###end p 4
###begin p 5
Hyperuricemia is commonly associated with other known risk factors for cardiovascular disease, such as obesity, hyperlipidemia, and hypertension, and in large epidemiological surveys, such as the Framingham study, it has been related to the occurrence of myocardial infarction. Yet, these associations are not fully understood.
###end p 5
###begin p 6
###xml 120 125 120 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
Therefore, we studied a population of Korean elderly males, in order to investigate the relationships between the C677T MTHFR mutation and serum uric acid, and with other variables traditionally associated with cardiovascular risk.
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
Study population
###end title 8
###begin p 9
###xml 846 847 838 839 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 41 44 <span type="species:ncbi:9606">men</span>
Three hundred and twenty-seven unrelated men, aged 40 yr or more, were recruited into the study after obtaining informed consent. All subjects underwent clinical examinations at Dong-A University Hospital between September 2002 and June 2003. None of the subjects were diagnosed as having gout or renal failure (>1.5 mg/dL of serum creatinine). The mean age of the subjects was 51.9 yr (range, 40-81 yr). The percentages of subjects with hypertension (systolic blood pressure, 160 mmHg or diastolic blood pressure, >/=95 mmHg), diabetes mellitus or impaired glucose tolerance (hemoglobin A1c (HbA1c), >/=6.5%), hypercholesterolemia (plasma total cholesterol, >/=220 mg/dL), and hyperglyceridemia (triglycerides, >/=150 mg/ dL) were 11.2%, 4.7%, 21.9% and 24.2%, respectively. Body mass index (BMI) was computed as weight (kg) divided by height (m2). Data on alcohol intake and smoking habits were obtained by interview. The subjects were asked to quantify their consumption of alcohol in terms of the kind of alcoholic beverage usually drunk and the minimum consumption per week. Alcohol intakes were then converted into grams of alcohol per day. The number of cigarettes smoked per day was also noted.
###end p 9
###begin title 10
Blood sample collection and DNA extraction
###end title 10
###begin p 11
###xml 49 61 <span type="species:ncbi:9606">participants</span>
A venous blood sample was drawn from each of the participants. DNA was extracted, using a Wizard Genomic DNA Purification Kit (Promega, Madison, U.S.A.), and stored at -20℃ until analyzed. Serum was used for clinical chemistry laboratory examinations at Dong-A University Hospital.
###end p 11
###begin title 12
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
MTHFR genotyping
###end title 12
###begin p 13
###xml 291 292 291 292 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 519 521 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 792 796 784 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hinf</italic>
###xml 894 898 886 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hinf</italic>
Polymerase chain reaction (PCR) was carried out using a PCR thermal cycler (TP2000; Takara Biomedicals, Kyoto, Japan). Thirty microliters of reaction mixture contained 200 ng of genomic DNA in 1x Expanded High Fidelity buffer (Boehringer Mannheim, Amsterdam, The Netherland) with 1.5 mM MgCl2, 250 microM dNTPs, 0.5 microM primers, and 0.7 units of Expand High Fidelity PCR System Enzyme Mix (Boehringer Mannheim). The sequences of the primers were as follows: 5'-TGAAGGAGGTGTCTGCGGGA-3' and 5'-AGGACGGTGCGGTGAGAGTG-3'(11). The conditions for PCR included an initial denaturation at 94℃ for 3 min, followed by 30 cycles of denaturation at 94℃ for 1 min, annealing at 55℃ for 2 min, extension at 72℃ for 3 min, and a final extension at 72℃ for 7 min. The amplified products were digested with HinfI (New England Biolabs, Beverly, MA, U.S.A.) at 37℃ for 4 hr. The C-to-T transition creates a new HinfI site. Digested products were electrophoresed in 3% agar gel.
###end p 13
###begin title 14
Biochemical determinations
###end title 14
###begin p 15
The following clinical chemistry variables were determined in serum by standard enzymatic methods: total cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides, glucose, uric acid, creatinine, urea, total protein, alanine aminotransferase, aspartate aminotransferase, gamma-glutamyltranspeptidase, and alkaline phosphatase. A whole blood cell count was taken for each subjects.
###end p 15
###begin title 16
Statistical analyses
###end title 16
###begin p 17
###xml 226 231 226 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 382 387 382 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
For statistical purposes, all variables showing a non-Gaussian distribution were logarithmically transformed. Analysis of variance (ANOVA) and Scheff's F-test were used to compare the means of subjects classified according to MTHFR genotype. The odds ratio (OR) and 95% confidence interval (95% CI) were calculated to estimate the relative risk of hyperuricemia associated with the MTHFR genotype. Study variables were correlated with uric acid levels, using Pearson's correlation coefficient test or Spearman's correlation coefficient by rank test.
###end p 17
###begin p 18
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 264 269 264 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
To allow for the independent contribution of MTHFR genotype and other variables to serum uric acid, multiple regression analysis were performed, including some of the variables significantly associated with serum uric acid in univariate analysis. In the analysis, MTHFR genotypes were designated as follows: C/C=0, C/T=1, T/T=2 (10). Other variables are presented as continuous form. Analyses were performed using SPSS 10.1 (U.S.A.) and Epi-Info 2002 (WHO).
###end p 18
###begin title 19
RESULTS
###end title 19
###begin title 20
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
Distribution of MTHFR genotypes
###end title 20
###begin p 21
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
The distribution of MTHFR genotypes was: C/C, 35.8%; C/T, 49.5%; T/T, 14.7%. Alle frequencies were 60.5% for the C allele and 39.5% for the T allele. These findings were consistent with previous Korean reports (12, 13).
###end p 21
###begin title 22
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
Physical and biochemical variables in subjects by MTHFR genotype
###end title 22
###begin p 23
###xml 82 87 82 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 110 117 110 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 225 230 225 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
The distribution of physical and biochemical variables, in subjects classified by MTHFR genotype, is shown in Table 1. For all variables, except for uric acid and creatinine, no significant differences were found between the MTHFR genotype subjects groups.
###end p 23
###begin title 24
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
MTHFR genotype and uric acid level
###end title 24
###begin p 25
###xml 58 65 58 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 144 149 144 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 170 171 170 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 349 350 343 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The serum uric acid levels for each genotype are shown in Table 2. The serum uric acid levels differed significantly in subjects with different MTHFR genotypes (F=7.555; p=0.001). Homozygotes for the MTHFR mutation had a significantly higher mean uric acid level (6.33+/-0.97 mg/dL mean+/-SD) than those without (5.54+/-1.26 mg/dL Scheffe's F-test, p=0.005), whereas heterozygotes had an intermediate value (5.91+/-1.18 mg/dL). Thus, a trend towards an increasing uric acid level was observed as the number of T allele copies increased.
###end p 25
###begin p 26
###xml 12 19 12 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 405 406 401 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 419 420 415 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 547 548 541 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 561 562 555 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
As shown in Table 2, subjects were classified into two groups based on uric acid levels: a low uric acid group (<7.0 mg/dL) and a high uric acid group (>/=7.0 mg/dL). The value of 7.0 mg/dL represents the upper limit of the normal range of serum uric acid in all males in our laboratory, and thus was chosen as a cut-off value. The genotype frequencies differed significantly between these two groups (chi2=9.44; df=2; p=0.009). The T allele frequency was also significantly greater in the high uric acid group than in the low uric acid group (chi2=8.76; df=1; p=0.003).
###end p 26
###begin p 27
###xml 146 153 146 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 196 197 196 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 207 208 207 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The calculated odds ratios and the 95% CIs for the C/T and the T/T genotypes were 2.10 (1.13-3.95) and 3.33 (1.29-8.61), versus the C/C genotype (Table 3). Both of these effects were significant (p=0.01 and p=0.005), suggesting that the T allele has a codominant effect on the risk of hyperuricemia.
###end p 27
###begin title 28
Univariate regression analyses
###end title 28
###begin p 29
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
Univariate analysis, serum uric acid is correlated with MTHFR genotype (number of copies of T allele per subject), BMI, diastolic blood pressure, triglycerides, blood glucose, total protein, creatinine, blood urea nitrogen, and hematocrit. No relationship was found between the uric acid level and other factors (age, total cholesterol, HDL-cholesterol, total protein, HbA1c (%), alkaline phosphatase, alcohol, and smoking).
###end p 29
###begin p 30
###xml 331 336 331 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 384 389 384 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 459 460 459 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
To exclude possible biases caused by the presence of subjects with hypertension, diabetes mellitus or impaired glucose tolerance, hypercholesterolemia, or hyperglyceridemia, subjects with each of these conditions were left out of the list in turn. Leaving out subjects with any of these conditions did not change the results as to MTHFR genotype. The correlation coefficients between MTHFR genotype and uric acid level fluctuated between 0.195 and 0.237, but p values remained below 0.001.
###end p 30
###begin title 31
Multiple regression analyses
###end title 31
###begin p 32
###xml 238 245 238 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 247 252 247 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
To assess the independent contribution of the variables to serum uric acid levels, multiple regression analysis was performed, which included all variables significantly associated with serum uric acid by univariate analyses. As shown in Table 3, MTHFR, BMI, diastolic blood pressure, log-triglycerides, and creatinine were found to be independently associated with serum uric acid levels, whereas, systolic blood pressure, blood glucose, total protein and hematocrit did not.
###end p 32
###begin title 33
DISCUSSION
###end title 33
###begin p 34
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 272 277 272 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 189 197 <span type="species:ncbi:9606">patients</span>
Frosst et al. proposed the C677T MTHFR mutation as a candidate for cardiovascular disease risk (11). However, the majority of studies and a recent meta-analysis of more than 6000 genotyped patients and controls have failed to confirm this (14). We presumed that the C677T MTHFR mutation could exert its atherogenic role at least partially by association with other recognized risk factors.
###end p 34
###begin p 35
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 169 174 169 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 357 360 <span type="species:ncbi:9606">men</span>
Motti et al. found a relationship between the C677T MTHFR mutation and serum uric acid (10). Their data shows that, increases in homocysteine in subjects with the C677T MTHFR mutation are paralleled by increases in serum uric acid levels. However, their subjects were an inseparable mixture of genders and ages; though higher uric acid levels were found in men (18).
###end p 35
###begin p 36
###xml 128 133 128 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 174 181 174 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 488 495 488 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 553 558 553 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 614 621 614 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 31 34 <span type="species:ncbi:9606">men</span>
In our study of Korean elderly men, a dose-dependent relationship was found between the number of copies of the T allele of the MTHFR gene and serum uric acid concentration (Table 1). Compared with the low uric acid group, the prevalence of the T/T genotype and the frequency of the T allele were higher in the group with elevated uric acid levels. The calculated odds ratio and 95% CI of hyperuricemia showed an increased risk of the C/T and T/T genotypes, rather than the C/C genotype (Table 2). Multivariate analysis also demonstrated that the C677T MTHFR mutation is an independent predictor of hyperuricemia (Table 3).
###end p 36
###begin p 37
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
Serum uric acid is usually considered a marker of renal dysfunction, and a risk factor of renal disease progression. In addition, more recent studies suggest that elevated serum uric acid predict cardiovascular disease and cerebrovascular accidents (15-21). Although uric acid was thought to be an inert endproduct of purine metabolism, and without physiological significance, except in gouty diathesis.
###end p 37
###begin p 38
###xml 252 253 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 482 487 482 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
Possible mechanisms underlying these associations may be presented. First, adenosine originating from S-adenosyl-homocysteine, and preferentially incorporated into a precursor pool for uric acid, would link the syntheses of homocysteine and uric acid (9). Second, in subjects with the T/T genotype, renovascular atherosclerosis or the complications of systemic vascular disease may reduce the renal clearance of uric acid, resulting in elevated serum uric acid (10). Therefore, the MTHFR mutation may be a risk factor that is involved in multiple metabolic pathways related to vascular diseases.
###end p 38
###begin p 39
###xml 107 115 <span type="species:ncbi:9606">patients</span>
However, it remains a matter of debate as to whether uric acid is an independent predictor of mortality in patients with cardiovascular disease, or whether it represents only an indirect marker of adverse outcome by reflecting the association between uric acid and other cardiovascular risk factors
###end p 39
###begin p 40
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 235 240 235 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
In this study, by comparing serum uric acid levels with the C677T MTHFR mutation, and with other variables by univariate analysis and multiple regression analysis. Five factors were found to be associated with hyperuricemia: the C677T MTHFR mutation, diastolic blood pressure, creatinine, triglycerides, and BMI. Compared with these factors, itself, may contribute less to hyperuricemia, because it showed a lower standard partial regression coefficient to serum uric acid.
###end p 40
###begin p 41
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
To prevent cardiovascular disorders in those who carry the C677T MTHFR mutation, supplementation with folate, vitamin B6 and vitamin B12 has been recommended (22), because inter-individual variation in homocysteine levels are related to other biological traits. The regulation of homocyteine is an example of a nutritional/genetic interaction, in which dietary habits (i.e. the intake of folic acid) play an important role, in addition, to strategies aimed at lowering serum uric acid levels, such as weight control and reducing the intake of foods containing purines.
###end p 41
###begin p 42
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 325 330 325 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
The present study shows that mutation of the MTHFR gene may be a risk factor for hyperuricemia in the Korean elderly population. In addition, the study identifies four other factors associated with hyperuricemia. Thus, we propose the probable need for a medical management strategy for those who are homozygous for the C677T MTHFR mutation, and the need for additional longitudinal study to determine the mechanism and role of uric acid as a risk factor of cardiovascular disease.
###end p 42
###begin p 43
This paper was supported by the Dong-A University Research Fund in 2003.
###end p 43
###begin article-title 44
Disorders of transsulphuration
###end article-title 44
###begin article-title 45
Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases
###end article-title 45
###begin article-title 46
Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease
###end article-title 46
###begin article-title 47
[Mutations in the methylene-tetrahydrofolate reductase gene and Down syndrome]
###end article-title 47
###begin article-title 48
Homocysteine and atherothrombosis
###end article-title 48
###begin article-title 49
Protein-bound homocysteine. A possible risk factor for coronary artery disease
###end article-title 49
###begin article-title 50
Elevated plasma homocysteine concentration as a possible independent risk factor for stroke
###end article-title 50
###begin article-title 51
Features, symptoms, and neurophysiological findings in stroke associated with hyperhomocysteinemia
###end article-title 51
###begin article-title 52
Role of blood pressure, uric acid, and hemorheological parameters on plasma homocyst(e)ine concentration
###end article-title 52
###begin article-title 53
Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine and other risk factors for vascular disease
###end article-title 53
###begin article-title 54
A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase
###end article-title 54
###begin article-title 55
The C677T mutation in the methylenetetrahydrofolate reductase gene in Koreans
###end article-title 55
###begin article-title 56
Genetic polymorphisms of 5,10-methylene-tetrahydrofolate reductase (MTHFR C677T and A1298C) in healthy Korean
###end article-title 56
###begin article-title 57
Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis
###end article-title 57
###begin article-title 58
Uric acid: a risk factor for coronary heart disease
###end article-title 58
###begin article-title 59
The relationship of serum uric acid to hypertension and ischemic heart disease in Hisayama population
###end article-title 59
###begin article-title 60
Hyperuricemia as a risk factor of coronary heart disease: the Framingham study
###end article-title 60
###begin article-title 61
Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study
###end article-title 61
###begin article-title 62
Serum urate and the risk of major coronary heart disease events
###end article-title 62
###begin article-title 63
###xml 51 59 <span type="species:ncbi:9606">patients</span>
Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus
###end article-title 63
###begin article-title 64
Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study
###end article-title 64
###begin article-title 65
Homocyst(e)ine and arterial occlusive disease
###end article-title 65
###begin p 66
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
Clinical data for subjects grouped by methylene tetrahydrofolate reductase (MTHFR) genotype
###end p 66
###begin p 67
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
*p<0.05. The values in different MTHFR genotypes (means+/-SD) were compared by analysis of variance (ANOVA). BMI, Body mass index; HDL, high density lipoprotein.
###end p 67
###begin p 68
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
Odds ratios of hyperuricemia associated with MTHFR genotypes
###end p 68
###begin p 69
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 4 5 2 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 18 19 16 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 90 96 88 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 99 100 90 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 113 114 104 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
*chi2=9.44; df=2; p=0.009: genotype frequencies differed significantly in the two groups. daggerchi2=8.76; df=1; p=0.003; T allele frequency was higher in the high uric acid group than in the low uric acid group.
###end p 69
###begin p 70
CI, Confidence interval.
###end p 70
###begin p 71
Multiple regression analysis using serum uric acid as dependent variable
###end p 71
###begin p 72
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
*p<0.05.
###end p 72
###begin p 73
St. beta, standardized beta coefficient.
###end p 73

